Nabi
Executive Summary
Company acquires exclusive worldwide rights to distribute Aloprim (allopurinol) in the U.S. from Catalytica Pharmaceuticals. Catalytica acquired Aloprim's marketing and manufacturing rights from Glaxo Wellcome, which marketed the drug under the tradename Zyloprim